Genetic risk information for coronary heart disease leads to lower bad cholesterol

November 09, 2015

ORLANDO, Fla. - A group of researchers led by Mayo Clinic has discovered that disclosing genetic risk for coronary heart disease (CHD) results in lower low-density lipoprotein cholesterol (LDL), also known as bad cholesterol. The findings of the Myocardial Infarction Genes (MI-GENES) Study were presented today at the annual American Heart Association Scientific Sessions 2015 as a late-breaking clinical trial.

In this study, the investigators tested the hypothesis that incorporating genetic risk information into CHD risk estimates would lead to lowering of LDL levels. Participants were randomized to receive a CHD risk estimate that included genetic risk information versus an estimate based on conventional risk factors alone. Conventional risk factors include high blood pressure, diabetes, physical inactivity and a history of smoking. Six months after risk disclosure, the LDL levels were nearly 10 milligrams per deciliter of blood lower in those randomized to receive genetic risk information. The lower LDL levels resulted from a greater proportion of individuals in this group being started on statin medication.

"This study demonstrates for the first time that disclosing genetic risk information for a common disease such as CHD can result in changes in a relevant health outcome, in this case, LDL levels," says Iftikhar Kullo, M.D., Mayo Clinic cardiologist and lead author. "The study also demonstrates the feasibility of placing genetic risk information into the electronic health record to empower patients and physicians to make decisions related to initiation of a statin medication. This is an important advance in the area of precision medicine for cardiovascular diseases."

The MI-GENES Study included 207 people, ages 45-65, with no known atherosclerotic vascular disease who were not on a statin and were at intermediate risk for CHD. The 10-year probability of heart attack was 5 to 20 percent. They were randomized to receive a 10-year probability of heart disease based on conventional risk factors alone versus conventional risk factors plus a genetic risk score (GRS). The GRS is derived from 28 genetic variants associated with CHD risk. For both groups, heart disease risk was disclosed by a genetic counselor, followed by a discussion with a physician about statin use. Participants' LDL levels were checked at three and six months.

LDL cholesterol transports cholesterol particles throughout the body and can build up in the walls of arteries, making them hard and narrow and may cause heart attacks. CHD remains the leading cause of death in the U.S. Often, the first manifestation is sudden death or heart attack.

"Our ability to predict the risk of an individual to suffer such an event is somewhat limited," Dr. Kullo says. "Incorporating genetic risk information into CHD risk estimates may improve our ability to more precisely identify individuals at risk."

The study was one of the genomic medicine pilots initiated in the last phase of the Electronic Medical Records and Genomics Network that is funded by the National Human Genome Research Institute.
Co-authors are: Hayan Jouni, M.D.; Iyad Isseh, M.B.B.S.; Erin Austin, Ph.D.; Teresa Kruisselbrink, M.S., C.G.C.; Sherry-Ann Brown, M.D., Ph.D.; Victor Montori, M.D.; Raad Haddad, M.B.B.S.; Daniel Schaid, Ph.D.; and Kent Bailey, Ph.D., all of Mayo Clinic; Ulrich Broeckel, M.D., Medical College of Wisconsin; and Robert Green, M.D., Brigham and Women's Hospital and Harvard Medical School.

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit or

MEDIA CONTACT: Traci Klein, Mayo Clinic Public Affairs, 507-990-1182,

Mayo Clinic

Related Coronary Heart Disease Articles from Brightsurf:

Women with coronary artery wall thickness at risk for heart disease
The thickness of the coronary artery wall as measured by MRI is an independent marker for heart disease in women, according to a new study.

E-cigarettes linked to heart attacks, coronary artery disease and depression
Concerns about the addictive nature of e-cigarettes -- now used by an estimated 1 out of 20 Americans -- may only be part of the evolving public health story surrounding their use, according to data being presented at the American College of Cardiology's 68th Annual Scientific Session.

Coronary calcium levels a better predictor of patients at risk for coronary heart disease
A new study presented at the American Heart Association Scientific Session conference found that testing a patient's coronary calcium levels is a better predictor of blocked coronary arteries at risk for a heart attack and the need for revascularization than standard risk-assessment equations used in medical practice today.

Coronary heart disease: DMP could be extended by two topics
Almost all health care aspects need to be updated. The already third search update for guidelines shows that their number and quality have increased notably in 10 years.

Learning about coronary heart disease from women
While many risk factors of CHD, such as smoking, high blood pressure and age, are common among men and women, some metabolic risk factors, such as being diabetic, are more strongly associated with increased risk of CHD in women than in men.

Cardiorespiratory fitness is essential to reduce risk of coronary heart disease
Coronary heart disease (CHD) is a leading cause of death for men in the US.

New study highlights smoking intensity in coronary heart disease risk
Increased relative risks for coronary heart disease (CHD) have long been associated with smoking, and traditionally they have been dependent on the number of cigarettes smoked a day, smoking intensities, and total exposure over time.

Pessimism associated with risk of death from coronary heart disease
Pessimism seems to be a strong risk factor for death from coronary heart disease, while optimism does not protect from it, according to a study published in the open-access journal BMC Public Health that involved 2,267 middle-aged and older Finnish men and women.

Study finds large decrease in coronary heart disease in US
The incidence of coronary heart disease in the US declined nearly 20 percent from 1983 to 2011, according to a study appearing in the Nov.

Americans are getting heart-healthier: Coronary heart disease decreasing in the US
Coronary heart disease is one of the leading causes of death in the United States.

Read More: Coronary Heart Disease News and Coronary Heart Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to